Cargando…
A Prospective Evaluation of Novel Renal Biomarkers in Patients With Lymphoma Receiving High-Dose Methotrexate
Autores principales: | Barreto, Jason N., Kashani, Kianoush B., Mara, Kristin C., Rule, Andrew D., Lieske, John C., Giesen, Callen D., Thompson, Carrie A., Leung, Nelson, Witzig, Thomas E., Barreto, Erin F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263243/ https://www.ncbi.nlm.nih.gov/pubmed/35812294 http://dx.doi.org/10.1016/j.ekir.2022.03.013 |
Ejemplares similares
-
Tissue Inhibitor Metalloproteinase-2 and Insulin-Like Growth Factor Binding Protein-7 Kinetics Following Exposure to High-Dose Methotrexate
por: Barreto, Jason N., et al.
Publicado: (2023) -
Propsective evaluation of high‐dose methotrexate pharmacokinetics in adult patients with lymphoma using novel determinants of kidney function
por: Barreto, Jason N., et al.
Publicado: (2021) -
Incorporating Cystatin C to Predict Methotrexate Elimination in Patients with CNS Lymphoma and Suspicious Renal Function
por: Barreto, Jason N., et al.
Publicado: (2018) -
Clinician perspectives on inpatient cystatin C utilization: A qualitative case study at Mayo Clinic
por: Markos, James Roland, et al.
Publicado: (2020) -
Serum cystatin C predicts vancomycin trough levels better than serum creatinine in hospitalized patients: a cohort study
por: Frazee, Erin N, et al.
Publicado: (2014)